Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Aphakia, Postcataract

3,4-dihydroxyphenylacetic acid has been researched along with Aphakia, Postcataract in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Aphakia, Postcataract: Absence of the crystalline lens resulting from cataract extraction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iuvone, PM1
Haque, R1
Fernandes, A1
Lambert, SR1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Aphakia, Postcataract

ArticleYear
Neonatal aphakia is associated with altered levels of dopamine metabolites in the non-human primate retina.
    Experimental eye research, 2015, Volume: 140

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Aphakia, Postcataract; Axial Length, Eye;

2015